National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

Found 9,352 cases where Vaccine is MENB

Case Details

This is page 31 out of 936

Result pages: prev   22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40   next


VAERS ID: 616642 (history)  
Form: Version 1.0  
Age: 51.0  
Sex: Female  
Location: Unknown  
Vaccinated:2015-06-01
Onset:2015-06-01
   Days after vaccination:0
Submitted: 2015-10-29
   Days after onset:150
Entered: 2015-12-29
   Days after submission:61
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 146101 / UNK AR / SYR

Administered by: Other       Purchased by: Other
Symptoms: Accidental exposure to product, Exposure via direct contact, Eye irrigation, No adverse event
SMQs:, Medication errors (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: PHEH2015US016326

Write-up: Case number PHEH2015US016326, is an initial spontaneous report from a health care professional received on 18 Aug 2015, with a follow up report from a health care professional received on 06 Oct 2015. This report refers to a 51 year old female patient. Her vaccination history included administration of first dose of BEXSERO, (batch number and expiry date: not reported) on an unknown date. No concomitant medication was reported. The patient was vaccinated with second dose of BEXSERO, (batch number: 146101, expiry date: not reported) into the deltoid on 01 Jun 2015 at 02:33 PM. The administering nurse splashed a "liquid of unknown origin" to face hitting right eye, lip and mouth when attempting to place the BEXSERO vaccine syringe in the sharps container. Patient rinsed her eye in the sink and did not seek medical attention. She did not report further incidents or follow ups on this incident. No adverse event was reported following accidental exposure to product. Follow up report from a health care professional received on 06 Oct 2015: Updated patient initials, added vaccination history, batch number, vaccination date and time, region of administration, event verbatim and reporter''s comment updated.


VAERS ID: 616667 (history)  
Form: Version 1.0  
Age:   
Sex: Unknown  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 2015-10-29
Entered: 2015-12-29
   Days after submission:61
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS - / UNK UN / SYR

Administered by: Other       Purchased by: Other
Symptoms: Headache, Pain, Vomiting
SMQs:, Acute pancreatitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: PHEH2015US015227

Write-up: Case number PHEH2015US015227 is an initial spontaneous report from a nurse received on 03 Aug 2015. This report refers of unspecified age and gender. Medical history and concomitant medications were not reported. The patient was vaccinated with BEXSERO, (batch number: unknown) on an unknown date. On an unknown date after the vaccination the patient had vomiting, pain and headache. The outcome, seriousness and causality assessment of the events was unknown.


VAERS ID: 616669 (history)  
Form: Version 1.0  
Age: 18.0  
Sex: Female  
Location: Unknown  
Vaccinated:2015-08-03
Onset:2015-08-03
   Days after vaccination:0
Submitted: 2015-10-29
   Days after onset:87
Entered: 2015-12-29
   Days after submission:61
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 146101 / UNK LA / IM

Administered by: Other       Purchased by: Other
Symptoms: Pain, Swelling
SMQs:, Anaphylactic reaction (broad), Angioedema (broad), Haemodynamic oedema, effusions and fluid overload (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: PHEH2015US016640

Write-up: Case number PHEH2015US016640, is an initial spontaneous report from a health care professional received on 24 Aug 2015.This report refers to an 18 years old female patient. Medical history and concomitant medications were not reported. She was vaccinated with BEXSERO, (batch number: 146101, expiry date: 30 Apr 2016) into left arm intramuscularly on 03 Aug 2015. On the same day following the vaccination the patient experienced pain and swelling. The outcome, seriousness and causality of the event were not reported.


VAERS ID: 616670 (history)  
Form: Version 1.0  
Age: 19.0  
Sex: Female  
Location: Unknown  
Vaccinated:2015-10-09
Onset:2015-10-09
   Days after vaccination:0
Submitted: 2015-10-29
   Days after onset:20
Entered: 2015-12-29
   Days after submission:61
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS - / UNK LA / SYR

Administered by: Other       Purchased by: Other
Symptoms: Injection site nodule, Pain in extremity
SMQs:, Extravasation events (injections, infusions and implants) (broad), Tendinopathies and ligament disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Loratadine
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: PHEH2015US020627

Write-up: Case number PHEH2015US020627, is an initial spontaneous report from a consumer received on 12 Oct 2015. This report refers to a 19-year-old female patient. Past medical history was not reported. Past medical vaccination included flu vaccine of unknown manufacture on 29 Sep 2015 (10 days prior to BEXSERO). Concomitant medication included loratadine (manufacturer unknown). She was vaccinated with BEXSERO (batch number and expiry date: not reported) at left arm on 09 Oct 2015. On same day, few hours after vaccination she started experiencing a sore arm, and there was a knot at the injection site. She stated that her arm was more sore than she usually experiences with vaccines, and had lasted longer than usual. The symptoms were improving, but not yet resolved. The seriousness and causality of events were not reported.


VAERS ID: 616923 (history)  
Form: Version 1.0  
Age: 17.0  
Sex: Female  
Location: Kansas  
Vaccinated:2015-12-28
Onset:2015-12-30
   Days after vaccination:2
Submitted: 2015-12-30
   Days after onset:0
Entered: 2015-12-31
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU4: INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) / SANOFI PASTEUR UI516AA / UNK LA / IM
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH J29757 / 2 RA / IM

Administered by: Private       Purchased by: Unknown
Symptoms: Erythema multiforme, Pruritus, Rash generalised
SMQs:, Severe cutaneous adverse reactions (narrow), Anaphylactic reaction (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Amoxicillin
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Examination by pediatrician
CDC Split Type:

Write-up: Erythema multiforme - onset of rash on feet on 12/30; progreesed to cover entire body as afternoon progressed, pruritis. Prednisone taper prescribed.


VAERS ID: 617495 (history)  
Form: Version 1.0  
Age: 19.0  
Sex: Female  
Location: Maryland  
Vaccinated:2015-12-23
Onset:2015-12-23
   Days after vaccination:0
Submitted: 2016-01-05
   Days after onset:13
Entered: 2016-01-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH L13515 / 2 LA / IM

Administered by: Private       Purchased by: Private
Symptoms: Lymphadenopathy, Oropharyngeal pain, Streptococcus test negative, Swollen tongue
SMQs:, Anaphylactic reaction (broad), Angioedema (narrow), Oropharyngeal allergic conditions (narrow), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Synthroid; Birth Control (Ortho tricyclin)
Current Illness: No
Preexisting Conditions: Celiac Disease, Hypothyroid (Hashimotos)
Allergies:
Diagnostic Lab Data: Unremarkable physical exam. Strep test negative.
CDC Split Type:

Write-up: Felt tongue was swollen, lymph nodes felt swollen, sore throat.


VAERS ID: 617692 (history)  
Form: Version 1.0  
Age: 16.0  
Sex: Female  
Location: Unknown  
Vaccinated:2015-10-29
Onset:0000-00-00
Submitted: 2016-01-04
Entered: 2016-01-05
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU4: INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) / GLAXOSMITHKLINE BIOLOGICALS - / UNK RA / UN
MEN: MENINGOCOCCAL (NO BRAND NAME) / UNKNOWN MANUFACTURER - / 2 LA / UN
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH - / 1 UN / UN

Administered by: Other       Purchased by: Other
Symptoms: Headache
SMQs:

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: US2015GSK172249

Write-up: This case was reported by a nurse via licensee and described the occurrence of headache in a 16-year-old female patient who received Influenza vaccine Quadrivalent. Co-suspect products included Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine and Meningitis B vaccine. On 29th October 2015, the patient received Influenza vaccine Quadrivalent, the 2nd dose of Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine and the 1st dose of Meningitis B vaccine. In 2015, less than a month after receiving Influenza vaccine Quadrivalent and Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine, the patient experienced headache. In 2015, the outcome of the headache was recovered/resolved. The reporter considered the headache to be related to Influenza vaccine Quadrivalent and Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine. Additional details were provided as follows: On Thursday, 29th October 2015, the patient received 1st dose of TRUMENBA and 2nd dose of Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine in her left arm. On the same day, the patient received Influenza vaccine Quadrivalent in her right arm. The patient then complained of experiencing a bad headache for two and half days and this was reported by patient''s mother at the office. The patient''s mother began some sort of medication at home for the patient''s headache but she did not say what the medication was. The sales representative of other manufacturer reported that he did not have any patient details including name, medical history and other details and added that the doctor''s office will be happy to share other information. The reporter mentioned that the doctor did not know but he suspect that the adverse event was related to the vaccines. The doctor also did not know if it was combination of the vaccines or a single vaccine and they were actually calling to find out that and the reporter told them to call Medical Affairs to find the information. The sales representative called back to confirm the reporter of the adverse event and nurse as confirmed as reporter who had same address and contact as of doctor and added that he did not have the email address of the doctor. Limited information was available to the sales representative. It was unknown if the reporter considered the headache to be related to TRUMENBA. This case has been linked to case US2015GSK172261, reported by the same reporter.


VAERS ID: 617744 (history)  
Form: Version 1.0  
Age: 16.0  
Sex: Female  
Location: Unknown  
Vaccinated:2015-11-06
Onset:2015-11-06
   Days after vaccination:0
Submitted: 2016-01-05
   Days after onset:60
Entered: 2016-01-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPVX: HPV (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK RA / UN
MEN: MENINGOCOCCAL (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK LA / UN
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH - / UNK LA / UN

Administered by: Other       Purchased by: Other
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Malaise, Pyrexia, Tenderness
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Extravasation events (injections, infusions and implants) (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: US2015GSK172261

Write-up: This case was reported by a nurse via licensee and described the occurrence of injection site swelling in a 16-year-old female patient who received Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine. Co-suspect products included Meningitis B vaccine and HPV vaccine. On 6th November 2015, the patient received Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine, Meningitis B vaccine and HPV vaccine. On 6th November 2015, less than a day after receiving Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine, the patient experienced injection site swelling and feeling unwell. On 7th November 2015, the patient experienced fever. In November 2015, the patient experienced injection site erythema, injection site warmth and injection site pain. The patient was treated with ibuprofen. On 8th November 2015, the outcome of the fever was recovered/resolved. On an unknown date, the outcome of the injection site swelling, feeling unwell, injection site erythema, injection site warmth and injection site pain were unknown. The reporter considered the injection site swelling, feeling unwell, fever, injection site erythema, injection site warmth and injection site pain to be related to Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine. Additional details were provided as follows: On 6th November 2015, the patient received Meningococcal polysaccharide groups A, C, W-135, Y conjugate vaccine and TRUMENBA in her left arm as well as Human Papillomavirus 9 valent vaccine in her right arm. On the same day, the patient complained that she had swelling at the base of her shoulder and she was feeling sick. Over the weekend, i.e. on 7th November 2015, 1 day after receiving the vaccines, the patient experienced fever on and off till 8th November 2015. The patient then received Ibuprofen. A day before time of reporting, on 9th November 2015, the patient visited the office. In November 2015, less than a week after receiving the vaccines, according to the nurse the patient''s shoulder look red, hot to touch and continued to complain of sharp pain and tenderness from the shoulder to the upper neck. The sales representative of other manufacturer did not have any patient details like her medication history and other details. The doctor did not know but they suspect that all the adverse events were related to the vaccines. The doctor did not know if it was the combination of the vaccines or a single vaccine and they were actually calling to find out that and the sales representative told them to call to find the information. The reporter was called back to confirm the reporter of the adverse event and nurse was confirmed to be the reporter who had same address and contact as of doctor. The reporter did not had email address of the doctor. The reporter had limited information regarding the patient. It was unknown if the reporter considered the injection site swelling, feeling unwell, fever, injection site erythema, injection site warmth and injection site pain to be related to TRUMENBA and Human Papillomavirus 9 valent vaccine. This case has been linked to case US2015GSK172249, reported by the same reporter.


VAERS ID: 617826 (history)  
Form: Version 1.0  
Age: 11.0  
Sex: Male  
Location: Florida  
Vaccinated:2016-01-05
Onset:2016-01-06
   Days after vaccination:1
Submitted: 2016-01-07
   Days after onset:1
Entered: 2016-01-07
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU3: INFLUENZA (SEASONAL) (FLUARIX) / GLAXOSMITHKLINE BIOLOGICALS A5L77 / 7+ OT / IM
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 148901A / 1 OT / IM
MNQ: MENINGOCOCCAL CONJUGATE (MENVEO) / NOVARTIS VACCINES AND DIAGNOSTICS A15065 / 1 OT / IM
TDAP: TDAP (ADACEL) / SANOFI PASTEUR U5267AA / 1 OT / IM

Administered by: Public       Purchased by: Public
Symptoms: Injection site cellulitis
SMQs:

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: NONE
Preexisting Conditions: Scoliosis deformity of spine
Allergies:
Diagnostic Lab Data: Cellulitis
CDC Split Type:

Write-up: Cellulitis on injection sites. Treatment of diphenhydramine 12.5 mg/5 mL was started on 1/7/16 for 10 days.


VAERS ID: 617857 (history)  
Form: Version 1.0  
Age: 19.0  
Sex: Male  
Location: Florida  
Vaccinated:2015-12-14
Onset:2015-12-15
   Days after vaccination:1
Submitted: 2015-12-28
   Days after onset:13
Entered: 2016-01-07
   Days after submission:10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (TRUMENBA) / PFIZER/WYETH L13515 / 1 LA / IM

Administered by: Private       Purchased by: Private
Symptoms: Chest X-ray, Electrocardiogram, Myocardial necrosis marker, Palpitations, Tachycardia
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Cardiomyopathy (broad), Dehydration (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: None
Preexisting Conditions: Prominent aortic root; Genetic testing done to rule out Marfan''s
Allergies:
Diagnostic Lab Data: EKG; Chest X-Ray; Cardiac enzymes
CDC Split Type:

Write-up: Patient experienced palpitations and tachycardia approximately 36 hrs after receiving TRUMENBA (meningitis B vaccine).


Result pages: prev   22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=31&VAX[]=MENB


Copyright © 2020 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166